ProPath :: Immunohistochemistry

TITLE	DESCRIPTION	LINK
December 2007	p24-gag Immunostaining as a marker of HIV infection in the Work-Up of Lymph Nodes with Unexplained Reactive Follicular Hyperplasia	View
July 2007	Immunohistochemistry in the diagnosis of Lyme Disease	View
June 2007	Phospho-STAT5 Immunostains as a Surrogate Marker for JAK2 V617F Mutations in non-CML Chronic Myeloproliferative Disorders	View
May 2007	TLE1 Immunostains in the Diagnosis of Synovial Sarcoma	View
April 2007	PAX-5	View
March 2007	The Role of Immunohistochemistry for ERCC1 in Determining Therapeutic Response in Non-Small Cell Lung Carcinomas	View
Feb 2007	Immunohistochemistry in the Diagnosis of Whipple's Disease	View
Jan 2007	Update on Immunohistochemistry of Germ Cell Tumors	View
Dec 2005	MDM2 and CDK 4 Immunostains in the Diagnosis of Atypical Lipomatous Tumor / Well-differentiated Liposarcoma and Dedifferentiated Liposarcoma	View
Nov 2005	Annexin A1: A New Marker for Hairy Cell Leukemia	View
Oct 2005	Utility of Immunostains for D2-40 in Diagnostic Pathology	View
Sept 2005	Immunohistochemical Markers of Prostate Carcinoma, Including Prostate-Specific Membrane Antigen (PSMA)	View
Aug 2005	Platelet Derived Growth Factor Receptor Alpha (PDGFR-α) Immunostains in the Identification of C-Kit Negative Gastrointestinal Stromal Tumors (GISTs).	View
July 2005	Immunohistochemistry in the Recognition of “Basal-like” or “Basaloid” Breast Carcinoma	View
June 2005	Immunohistochemical Features of Squamous Differentiation	View
May 2005	Immunohistochemistry in the recognition of respiratory syncytial virus (RSV) pneumonia	View
Apr 2005	Immunohistochemistry in the Differential Diagnosis of Clear Cell Carcinomas from the Kidney, Liver, and Lung	View
Mar 2005	Immunohistochemistry in Dermatofibrosarcoma protuberans (DFSP) vs. Dermatofibroma-Fibrous Histiocytoma (DF-FH)	View
Feb 2005	Ki-67 clone K-2: A useful marker of fat cells and lipoblasts	View
Jan 2005	Cytopathology-from an Immunohistochemist's Perspective	View
Dec 2004	Immunohistochemistry in the Differential Diagnosis of Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma	View
Nov 2004	Immunohistochemistry in the Recognition of Early Myocardial Infarction	View
Oct 2004	Immunohistochemistry in the Differential Diagnosis of Schwannoma and Neurofibroma	View
Sep 2004	Immunohistochemistry in Amyloidosis	View
Aug 2004	Differential Diagnosis of Cytokeratin "Dots"	View
Jul 2004	Immunostains for B-catenin in Diagnostic Pathology	View
Jun 2004	Using fluorescent in situ hybridization (UroVysion FISH) for monitoring of recurrence of urothelial carcinoma.	View
May 2004	Oct 3/4: A New Marker of Embryonal Carcinoma and Seminoma	View
Apr 2004	p63/P504S Antibody Cocktail in Prostate Biopsies	View
Mar 2004	Epidermal Growth Factor Receptor and Erbitux	View
Feb 2004	Perivascular Epithelioid Cell Tumors (PE Comas)	View
Jan 2004	Endogenous Biotin Artifact	View
Dec 2003	ZAP-70 in Chronic Lymphocytic Leukemia	View
Nov 2003	Cytokeratin AE1/AE3	View
Oct 2003	Immunohistochemistry in the Evaluation of Follicular or Nodular Lymphoid Lesions	View
Sep 2003	Immunohistochemistry in Lymph Node Histiocytosis	View
Aug 2003	Immunohistochemistry in the Evaluation of Atypical Epithelial Cells in Effusions	View
Jul 2003	TFE3 Immunostains in the Diagnosis of Alveolar Soft Part Sarcoma and Other Tumors	View
Jun 2003	Immunohistochemistry in Urothelial Dysplasia	View
May 2003	Anaplastic Lymphoma Kinase (ALK)	View
Apr 2003	Endocervical vs. Endometrial Adenocarcinoma: Update on Useful Immunohistochemical Markers	View
Feb 2003	Calretinin	View
Jan 2003	Immunohistochemistry in Forensic Pathology	View
Dec 2002	CDX2	View
Nov 2002	P504S	View
Oct 2002	Utility of Ki-67 (MIB-1) Immunostaining in Cervical Biopsies	View
Aug 2002	Ubiquitin Immunohistochemistry in Alzheimer's Disease	View
Sep 2002	Utility of p16 (INK4a) Immunostaining in Cervical Biopsies	View
Jul 2002	Breast Carcinoma vs. Pulmonary Adenocarcinoma	View
Jun 2002	Human Herpesvirus Type 8 (HHV8)	View
May 2002	High Molecular Weight Cytokeratin (34ßE12)	View
Apr 2002	Optimal Titering of Primary Antibodies (And the Dangerous Fallacy of "Predilute Ready-to-Use" Antibodies)	View
Mar 2003	Evaluation of Hydropic Placentas (Hydropic Degeneration vs. Partial Mole vs. Complete Mole)	View
Mar 2002	Tissue Protection Immunohistochemistry	View
Feb 2002	Recognition of Gluten Sensitivity	View
Jan 2002	Endocervical vs. Endometrial Adenocarcinoma	View
Dec 2001	True Positive vs. False Positive Staining	View
Nov 2001	Traps in Sentinel Lymph Node Biopsies	View
Oct 2001	Wilms Tumor Gene Protein (WT1)	View
Sep 2001	p63	View
Aug 2001	CD56 (NCAM)	View
Jul 2001	BCL-2	View
Jun 2001	Villin	View
May 2001	CD10	View
Apr 2001	Thyroid Transcription Factor-1 (TTF-1)	View
Mar 2001	Poorly Differentiated Prostate Adenocarcinoma Vs. Urothelial Carcinoma	View
Feb 2001	Immunophenotype of Renal Cell Carcinoma, "Clear Cell" Type	View
Jan 2001	hMLH1 and hMSH2: Important Immunohistochemical Markers for the Evaluation of Patients with Possible Hereditary Non-Polyposis Colon Cancer Syndrome	View
Dec 2000	Cytokeratin 5/6	View
Nov 2000	Gastrointestinal Stromal Tumors (GIST)	View
Oct 2000	Squamous Carcinoma vs. Poorly Differentiated GI Adenocarcinoma vs. Small Cell Carcinoma	View
Sep 2000	Antibodies Useful in the Diagnosis of Cutaneous Paget's Disease	View
Aug 2000	E-Cadherin: An Aid in Distinguishing Ductal from Lobular Breast Proliferations	View
Jul 2000	Myoepithelial Markers: An Aid in the Interpretation of Breast Biopsies	View
Jun 2000	Cat Scratch Disease Antibody Now Available	View